Feasibility of a Culturally Adapted Nurse-Led COPE Intervention for Caregivers of Children With Autism Spectrum Disorder

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorKhyber Medical University Peshawar

About this trial

This study aims to evaluate the feasibility of a culturally adapted, nurse-led Creating Opportunities for Parent Empowerment (COPE) intervention to improve the psychological wellbeing of primary caregivers of children with Autism Spectrum Disorder (ASD) in Pakistan. The study will use an exploratory sequential mixed-methods design comprising a qualitative needs assessment followed by a pilot randomized controlled feasibility trial. Qualitative interviews will identify caregivers' training needs and inform the cultural adaptation of the COPE intervention. Eligible caregivers will then be randomly assigned to either an intervention group receiving the culturally adapted COPE program in addition to routine care or a control group receiving routine care alone. The intervention consists of four weekly nurse-led sessions focusing on psychoeducation, cognitive restructuring, coping strategies, positive parenting, emotional regulation, and family resilience. Psychological wellbeing will be assessed using the Depression Anxiety Stress Scale-21 (DASS-21) at baseline and one month after the intervention. The study will also evaluate recruitment, retention, intervention adherence, acceptability, and implementation feasibility to inform the design of a future definitive randomized controlled trial.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Male or female primary caregivers aged 18 years or older.

Primary caregiver of a child with a confirmed diagnosis of Autism Spectrum Disorder (ASD).

Able to communicate in Urdu.

Willing and able to provide written informed consent.

Disqualifiers

Caregivers currently participating in another structured psychosocial, behavioral, or parenting intervention.

Caregivers with a diagnosed severe psychiatric illness or cognitive impairment that would interfere with participation.

Caregivers unable to communicate effectively in Urdu.

Caregivers who decline or are unable to provide informed consent.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Culturally Adapted Nurse-Led COPE Intervention

    Behavioral

    The intervention is a culturally adapted, nurse-led behavioral and psychoeducational program based on the Creating Opportunities for Parent Empowerment (COPE) framework. It is designed to improve the psychological wellbeing of primary caregivers of children with Autism Spectrum Disorder (ASD) by enhancing coping skills, emotional regulation, problem-solving abilities, and parenting confidence. The intervention comprises four weekly sessions of approximately 45 minutes each and includes education about ASD, cognitive restructuring, stress management, positive parenting strategies, guided problem-solving, and development of long-term coping and family resilience. The program is delivered by trained nurses using standardized educational materials, including presentations, audiovisual aids, and printed booklets.

  • Routine Hospital Care

    Other intervention

    Participants receive the standard care routinely provided by the hospital for families of children with Autism Spectrum Disorder. No components of the culturally adapted nurse-led COPE intervention are provided during the study period.

Treatment groups

77 Participants
are divided into 2 treatment groups
Group A: Culturally Adapted Nurse-Led COPE InterventionExperimental treatment 1 intervention
Group B: Routine CareOther 1 intervention

Trial outcomes

Primary outcomes

1

Change in Depression Score

Change in depression score measured using the Depression Anxiety Stress Scale-21 (DASS-21) Depression subscale. The depression subscale consists of 7 items, each scored from 0 (Did not apply to me at all) to 3 (Applied to me very much or most of the time). The summed subscale score is multiplied by 2, yielding a final score ranging from 0 to 42, with higher scores indicating greater depressive symptoms. The primary outcome is the change in depression score from baseline to one-month follow-up between the intervention and control groups.

Time frame
Baseline and 1 month after completion of the intervention.
2

Anxiety

Change in anxiety score measured using the Depression Anxiety Stress Scale-21 (DASS-21) Anxiety subscale. The anxiety subscale consists of 7 items, each scored from 0 (Did not apply to me at all) to 3 (Applied to me very much or most of the time). The summed subscale score is multiplied by 2, yielding a final score ranging from 0 to 42, with higher scores indicating greater anxiety symptoms. The primary outcome is the change in anxiety score from baseline to one-month follow-up between the intervention and control groups

Time frame
Baseline and 1 month after completion of the intervention.
3

Stress

Change in stress score measured using the Depression Anxiety Stress Scale-21 (DASS-21) Stress subscale. The stress subscale consists of 7 items, each scored from 0 (Did not apply to me at all) to 3 (Applied to me very much or most of the time). The summed subscale score is multiplied by 2, yielding a final score ranging from 0 to 42, with higher scores indicating greater stress symptoms. The primary outcome is the change in stress score from baseline to one-month follow-up between the intervention and control groups.

Time frame
Baseline and 1 month after completion of the intervention.

Secondary outcomes

Other outcomes

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Children Hospital Complex and Institute of Child HealthRecruiting38000, Faisalābad, Punjab ProvincePakistanPakistan

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Khyber Medical University Peshawar

Lead sponsor

Children Hospital Faisalabad

Collaborator